{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:11:32Z","timestamp":1779275492852,"version":"3.51.4"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"44","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,31]]},"abstract":"<jats:p>\n                    This study aimed to investigate a causal association between Klotho levels and the risk of B-cell lymphoma using a Mendelian randomization (MR) approach. We sought to determine if \u03b1-Klotho levels are causally linked to various subtypes of B-cell lymphoma, including diffuse large B-cell lymphoma, follicular lymphoma, Hodgkin lymphoma, and non-Hodgkin lymphoma. We obtained GWAS data for B-cell lymphomas from the FINN Large Cohort in the IEU database and \u03b1-Klotho levels from a meta-analysis of GWAS data. The primary analysis employed the inverse-variance weighted method, while sensitivity analyses utilized weighted median, MR-Egger, and weighted mode methods to validate results. Heterogeneity and pleiotropy of genetic instruments were assessed using leave-one-out sensitivity tests, the MR pleiotropy residual sum and outlier test (MR-PRESSO), and Cochran\n                    <jats:italic toggle=\"yes\">Q<\/jats:italic>\n                    test. Our analysis revealed no significant associations between \u03b1-Klotho levels and any subtype of B-cell lymphoma using inverse-variance weighted (IVW). The odds ratios and 95% confidence intervals indicated no significant relationship for diffuse large B-cell lymphoma, follicular lymphoma, Hodgkin lymphoma, or unspecified non-Hodgkin lymphoma. Heterogeneity tests and sensitivity analyses supported the robustness of these findings. Our comprehensive MR analysis suggests no causal relationship exists between Klotho levels and the risk of developing B-cell lymphomas.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000044963","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T17:01:09Z","timestamp":1763571669000},"page":"e44963","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Causal association between circulating Klotho levels and B-cell lymphoma: A 2-sample Mendelian randomization study"],"prefix":"10.1097","volume":"104","author":[{"given":"Zi","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Hematology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su","family":"Mao","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, National Clinical Research Center for Obstetric and Gynecologic Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daobin","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Hematology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260520","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/978-981-15-3532-1_12","article-title":"B cell lymphoma.","volume":"1254","author":"Meng","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"R2-20260520","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1053\/j.seminhematol.2023.11.004","article-title":"Epidemiology and etiology of diffuse large B-cell lymphoma.","volume":"60","author":"Wang","year":"2023","journal-title":"Semin Hematol"},{"key":"R3-20260520","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/bjh.15412","article-title":"How I manage patients with relapsed\/refractory diffuse large B cell lymphoma.","volume":"182","author":"Gisselbrecht","year":"2018","journal-title":"Br J Haematol"},{"key":"R4-20260520","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/2040620713505048","article-title":"Diffuse large B-cell lymphoma in adults aged 75 years and older: a single institution analysis of cause-specific survival and prognostic factors.","volume":"4","author":"Smith","year":"2013","journal-title":"Ther Adv Hematol"},{"key":"R5-20260520","doi-asserted-by":"crossref","first-page":"611","DOI":"10.14336\/AD.2016.1230","article-title":"Cancer and aging - the inflammatory connection.","volume":"8","author":"Zinger","year":"2017","journal-title":"Aging Dis"},{"key":"R6-20260520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15280\/jlm.2015.5.1.1","article-title":"Biological role of anti-aging protein klotho.","volume":"5","author":"Kim","year":"2015","journal-title":"J Lifestyle Med"},{"key":"R7-20260520","doi-asserted-by":"crossref","first-page":"101766","DOI":"10.1016\/j.arr.2022.101766","article-title":"Aging-suppressor klotho: prospects in diagnostics and therapeutics.","volume":"82","author":"Abraham","year":"2022","journal-title":"Ageing Res Rev"},{"key":"R8-20260520","doi-asserted-by":"crossref","first-page":"sfad276","DOI":"10.1093\/ckj\/sfad276","article-title":"Klotho: a potential therapeutic target in aging and neurodegeneration beyond chronic kidney disease-a comprehensive review from the ERA CKD-MBD working group.","volume":"17","author":"Kanbay","year":"2024","journal-title":"Clin Kidney J"},{"key":"R9-20260520","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3892\/or.2017.5744","article-title":"Klotho suppresses tumor progression via inhibiting IGF-1R signaling in T\u2011cell lymphoma.","volume":"38","author":"Zhou","year":"2017","journal-title":"Oncol Rep"},{"key":"R10-20260520","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13045-017-0391-5","article-title":"Klotho, an anti-aging gene, acts as a tumor suppressor and inhibitor of IGF-1R signaling in diffuse large B cell lymphoma.","volume":"10","author":"Zhou","year":"2017","journal-title":"J Hematol Oncol"},{"key":"R11-20260520","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s43586-021-00092-5","article-title":"Mendelian randomization.","volume":"2","author":"Sanderson","year":"2022","journal-title":"Nat Rev Methods Primers"},{"key":"R12-20260520","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/01.ede.0000215160.88317.cb","article-title":"Instrumental variables: application and limitations.","volume":"17","author":"Martens","year":"2006","journal-title":"Epidemiology"},{"key":"R13-20260520","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1080\/09603123.2023.2251406","article-title":"The association of COVID-19 with diffuse large B-cell lymphoma: a Mendelian randomization study.","volume":"34","author":"Chen","year":"2024","journal-title":"Int J Environ Health Res"},{"key":"R14-20260520","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1007\/s10238-023-01221-y","article-title":"Causal relationships between circulating inflammatory cytokines and diffuse large B cell lymphoma: a bidirectional Mendelian randomization study.","volume":"23","author":"Yu","year":"2023","journal-title":"Clin Exp Med"},{"key":"R15-20260520","doi-asserted-by":"crossref","first-page":"1171446","DOI":"10.3389\/fimmu.2023.1171446","article-title":"The causal effect of inflammatory bowel disease on diffuse large B-cell lymphoma: two-sample Mendelian randomization study.","volume":"14","author":"Lu","year":"2023","journal-title":"Front Immunol"},{"key":"R16-20260520","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/hmg\/ddab263","article-title":"GWAS meta-analysis followed by Mendelian randomization revealed potential control mechanisms for circulating \u03b1-Klotho levels.","volume":"31","author":"Gergei","year":"2022","journal-title":"Hum Mol Genet"},{"key":"R17-20260520","doi-asserted-by":"crossref","first-page":"618829","DOI":"10.3389\/fgene.2021.618829","article-title":"Mendelian randomization with refined instrumental variables from genetic score improves accuracy and reduces bias.","volume":"12","author":"Lin","year":"2021","journal-title":"Front Genet"},{"key":"R18-20260520","doi-asserted-by":"crossref","first-page":"1071616","DOI":"10.3389\/fimmu.2023.1071616","article-title":"Causal association between inflammatory bowel disease and hidradenitis suppurativa: a two-sample bidirectional Mendelian randomization study.","volume":"14","author":"Bao","year":"2023","journal-title":"Front Immunol"},{"key":"R19-20260520","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/s12916-020-01831-3","article-title":"The role of cortisol in ischemic heart disease, ischemic stroke, type 2 diabetes, and cardiovascular disease risk factors: a bi-directional Mendelian randomization study.","volume":"18","author":"Kwok","year":"2020","journal-title":"BMC Med"},{"key":"R20-20260520","doi-asserted-by":"crossref","first-page":"1183570","DOI":"10.3389\/fimmu.2023.1183570","article-title":"No genetic causal association between systemic lupus erythematosus and COVID-19.","volume":"14","author":"Xu","year":"2023","journal-title":"Front Immunol"},{"key":"R21-20260520","doi-asserted-by":"crossref","first-page":"808832","DOI":"10.3389\/fimmu.2022.808832","article-title":"No genetic causal association between periodontitis and arthritis: a bidirectional two-sample Mendelian randomization analysis.","volume":"13","author":"Yin","year":"2022","journal-title":"Front Immunol"},{"key":"R22-20260520","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in Mendelian randomization studies.","volume":"40","author":"Burgess","year":"2011","journal-title":"Int J Epidemiol"},{"key":"R23-20260520","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/gepi.22522","article-title":"Bias correction for inverse variance weighting Mendelian randomization.","volume":"47","author":"Mounier","year":"2023","journal-title":"Genet Epidemiol"},{"key":"R24-20260520","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R25-20260520","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator.","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"R26-20260520","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-Egger method.","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"R27-20260520","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jclinepi.2014.09.005","article-title":"Cochran\u2019s Q test was useful to assess heterogeneity in likelihood ratios in studies of diagnostic accuracy.","volume":"68","author":"Cohen","year":"2015","journal-title":"J Clin Epidemiol"},{"key":"R28-20260520","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1093\/ije\/dyx254","article-title":"Mendelian randomization with Egger pleiotropy correction and weakly informative Bayesian priors.","volume":"47","author":"Schmidt","year":"2018","journal-title":"Int J Epidemiol"},{"key":"R29-20260520","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"R30-20260520","doi-asserted-by":"crossref","first-page":"e0271898","DOI":"10.1371\/journal.pone.0271898","article-title":"Causal relationships between sex hormone traits, lifestyle factors, and osteoporosis in men: a Mendelian randomization study.","volume":"17","author":"Wang","year":"2022","journal-title":"PLoS One"},{"key":"R31-20260520","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.lungcan.2010.10.008","article-title":"Klotho is a novel biomarker for good survival in resected large cell neuroendocrine carcinoma of the lung.","volume":"72","author":"Usuda","year":"2011","journal-title":"Lung Cancer"},{"key":"R32-20260520","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1756-9966-29-99","article-title":"Klotho inhibits growth and promotes apoptosis in human lung cancer cell line A549.","volume":"29","author":"Chen","year":"2010","journal-title":"J Exp Clin Cancer Res"},{"key":"R33-20260520","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/labinvest.2015.86","article-title":"Klotho: a tumor suppressor and modulator of the Wnt\/beta-catenin pathway in human hepatocellular carcinoma.","volume":"96","author":"Tang","year":"2016","journal-title":"Lab Invest"},{"key":"R34-20260520","doi-asserted-by":"crossref","first-page":"6297","DOI":"10.3390\/cancers13246297","article-title":"A transgenic model reveals the role of klotho in pancreatic cancer development and paves the way for new klotho-based therapy.","volume":"13","author":"Arbel Rubinstein","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R35-20260520","doi-asserted-by":"crossref","first-page":"7094","DOI":"10.1038\/onc.2008.292","article-title":"Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer.","volume":"27","author":"Wolf","year":"2008","journal-title":"Oncogene"},{"key":"R36-20260520","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1038\/s41598-024-52616-0","article-title":"Protein interaction networks characterizing the A549 cells Klotho transfected are associated with activated pro-apoptotic Bim and suppressed Wnt\/beta-catenin signaling pathway.","volume":"14","author":"Matsumoto","year":"2024","journal-title":"Sci Rep"},{"key":"R37-20260520","first-page":"439","article-title":"Significant roles of anti-aging protein klotho and fibroblast growth factor23 in cardiovascular disease.","volume":"12","author":"Ding","year":"2015","journal-title":"J Geriatr Cardiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044963","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:01:30Z","timestamp":1779274890000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":37,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044963","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"2025-05-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}